Chemokine blockade: a new era in the treatment of rheumatoid arthritis?

被引：34

作者：

Haringman, JJ ^{[1
]}

Tak, PP ^{[1
]}

机构：

[1] Univ Amsterdam, Acad Med Ctr, Div Clin Immunol & Rheumatol, NL-1105 AZ Amsterdam, Netherlands

来源：

ARTHRITIS RESEARCH & THERAPY | 2004年 / 6卷 / 03期

关键词：

chemokines; rheumatoid arthritis; synovial tissue;

D O I：

10.1186/ar1172

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Blockade of chemokines or chemokine receptors is emerging as a new potential treatment for various immune-mediated conditions. This review focuses on the therapeutic potential in rheumatoid arthritis, based on studies in animal models and patients. Several knockout models as well as in vivo use of chemokine antagonists are discussed. Review of these data suggests that this approach might lead to novel therapeutic strategies in rheumatoid arthritis and other chronic inflammatory disorders.

引用

页码：93 / 97

页数：5

共 36 条

[11] A binding pocket for a small molecule inhibitor of HIV-1 entry within the transmembrane helices of CCR5 [J].

Dragic, T ;

Trkola, A ;

Thompson, DAD ;

Cormier, EG ;

Kajumo, FA ;

Maxwell, E ;

Lin, SW ;

Ying, WW ;

Smith, SO ;

Sakmar, TP ;

Moore, JP .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (10) :5639-5644

[12] Targeting of the chemokine receptor CCR1 suppresses development of acute and chronic cardiac allograft rejection [J].

Gao, W ;

Topham, PS ;

King, JA ;

Smiley, ST ;

Csizmadia, V ;

Lu, B ;

Gerard, CJ ;

Hancock, WW .

JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (01) :35-44

[13] CP-481,715, a potent and selective CCR1 antagonist with potential therapeutic implications for inflammatory diseases [J].

Gladue, RP ;

Tylaska, LA ;

Brissette, WH ;

Lira, PD ;

Kath, JC ;

Poss, CS ;

Brown, MF ;

Paradis, TJ ;

Conklyn, MJ ;

Ogborne, KT ;

McGlynn, MA ;

Lillie, BM ;

DiRico, AP ;

Mairs, EN ;

McElroy, EB ;

Martin, WH ;

Stock, IA ;

Shepard, RM ;

Showell, HJ ;

Neote, K .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (42) :40473-40480

[14] An antagonist of monocyte chemoattractant protein 1 (MCP-1) inhibits arthritis in the MRL-lpr mouse model [J].

Gong, JH ;

Ratkay, LG ;

Waterfield, JD ;

ClarkLewis, I .

JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (01) :131-137

[15] ESSENTIAL INVOLVEMENT OF INTERLEUKIN-8 (IL-8) IN ACUTE-INFLAMMATION [J].

HARADA, A ;

SEKIDO, N ;

AKAHOSHI, T ;

WADA, T ;

MUKAIDA, N ;

MATSUSHIMA, K .

JOURNAL OF LEUKOCYTE BIOLOGY, 1994, 56 (05) :559-564

[16] Chemokine blockade and chronic inflammatory disease: proof of concept in patients with rheumatoid arthritis [J].

Haringman, JJ ;

Kraan, MC ;

Smeets, TJM ;

Zwinderman, KH ;

Tak, PP .

ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 (08) :715-721

[17] Synovial stromal cells from rheumatoid arthritis patients attract monocytes by producing MCP-1 and IL-8 [J].

Hayashida, K ;

Nanki, T ;

Girschick, H ;

Yavuz, S ;

Ochi, T ;

Lipsky, PE .

ARTHRITIS RESEARCH, 2001, 3 (02) :118-126

[18]

HOSAKA S, 1994, CLIN EXP IMMUNOL, V97, P451

[19] Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2 [J].

Izikson, L ;

Klein, RS ;

Charo, IF ;

Weiner, HL ;

Luster, AD .

JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (07) :1075-1080

[20] Identification of surface residues of the monocyte chemotactic protein 1 that affect signaling through the receptor CCR2 [J].

Jarnagin, K ;

Grunberger, D ;

Mulkins, M ;

Wong, B ;

Hemmerich, S ;

Paavola, C ;

Bloom, A ;

Bhakta, S ;

Diehl, F ;

Freedman, R ;

McCarley, D ;

Polsky, I ;

Ping-Tsou, A ;

Kosaka, A ;

Handel, TM .

BIOCHEMISTRY, 1999, 38 (49) :16167-16177

← 1 2 3 4 →